| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |